Amedisys (AMED) Tops Q1 EPS by 11c; Offers FY22 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Amedisys (AMED) Tops Q1 EPS by 11c; Offers FY22 Guidance

Amedisys Reports First Quarter 2022 Financial Results and Reaffirms 2022 Guidance

April 27, 2022 4:05 PM EDT

BATON ROUGE, La., April 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2022.

Three-Month Periods Ended March 31, 2022 and 2021

Net service revenue increased $8.2 million to $545.3 million compared to $537.1 million in 2021.Net income attributable to Amedisys, Inc. of $31.7 million compared to $49.9 million in 2021.Net income attributable to Amedisys, Inc. per diluted share of $0.97 compared to $1.50 in 2021.

Adjusted Quarterly Results*

Adjusted EBITDA of $66.3 million compared to $78.6 million in 2021.Adjusted net income attributable to Amedisys, Inc. of $40.1 million compared to $51.1 million in... More